People · Operator
Named in public records as an officer, director or promoter · active 2012–2024 · Biotechnology, Other, Other Health Care, Other Technology, Electric Utilities, Healthtech
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Bolt Biotherapeutics, Inc. | — | Biotechnology | Series C | $178.6M | $433.3M | 2019 |
| ADB Holdings Group, LP | — | Other | Series A | $14.3M | $3.0M | 2023 |
| AION Biosystems, Inc. | — | Other Health Care | Series A | $10.3M | $13.2M | 2022 |
| OpinionLab, Inc. | — | Other Technology | Series A | $9.5M | $263.5M | 2012 |
| Texzon Utilities, LTD | — | Electric Utilities | Series A | $6.3M | $38.0M | 2019 |
| OpenTempo, Inc. | — | Other | Seed | $3.5M | $23.2M | 2013 |
| Seikowave Health Solutions, Inc. | — | Healthtech | Seed | $1.4M | $5.1M | 2018 |
| EXP World Holdings, Inc. | — | Other Technology | Pre-Seed | $760K | $32.2M | 2016 |
Richard Miller at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Richard Miller on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Robert Saunders | 1 | 18 |
| James Healy | 1 | 8 |
| Peter Moldt | 1 | 6 |
| Mahendra Shah | 1 | 5 |
| Edgar G Engleman | 1 | 5 |
| James H. Crook, Jr. | 1 | 5 |
| Steve Wilson | 1 | 4 |
| Alan Quasha | 1 | 4 |
| Stephen Wilson | 1 | 3 |
| Camilo Horvilleur | 1 | 3 |
| Mahendra G. Shah | 1 | 3 |
| Ashish Khanna | 1 | 3 |
| Hunter Witherington | 1 | 3 |
| Chih-Ping Liu | 1 | 2 |
| Wilson Orr | 1 | 2 |
| David Blechman | 1 | 2 |
| David Dornan | 1 | 2 |
| Ashish G. Khanna | 1 | 2 |
| Reiner Laus | 1 | 2 |
| Tom Wilson | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.